Luo ilmainen tili jotta voit seurata yrityksiä, osallistua foorumin keskusteluun sekä kommentoida meidän sisältöä. Valitse sinulle sopivin tili.
Oliko sinulla jo tili?
Follow this company like 9592 other investors.
Analyytikko
Redeye comment on the Q3 business review. Remedy reported an undramatic quarter that had a dramatic impact on the stock price, currently down almost 8%. The outlook for the year is unchanged and the business progressed as planned.
Redeye comments on Remedy’s stable H1-report. Revenue amounted to EUR 17.5 million which is above our estimated EUR 15.6 million.
Recently Remedy and the publisher 505 Games (Digital Bros) announced a co-publishing agreement in the universe of Control.
Redeye has made some minor changes in its estimates following the Q1-results in Remedy.
Remedy communicated quarterly figures for the first time as a public company this morning. Revenue and operating profit (EBIT) were slightly below our estimates.
